Phosphatidylcholine transfer protein inhibitor-1

• CAT Number: I041075
• CAS Number: 379723-99-6
• Molecular Formula: C21H17ClFN3O3S2
• Molecular Weight: 477.96
• Purity: ≥95%
• Synonyms: N-[[3-[(3-chlorophenyl)sulfamoyl]-4-methylphenyl]carbamothioyl]-4-fluorobenzamide
• InChI: InChI=1S/C21H17ClFN3O3S2/c1-13-5-10-17(24-21(30)25-20(27)14-6-8-16(23)9-7-14)12-19(13)31(28,29)26-18-4-2-3-15(22)11-18/h2-12,26H,1H3,(H2,24,25,27,30)
• InChIKey: NCOKQDHZCJTXLX-UHFFFAOYSA-N
• SMILES: CC1=C(C=C(C=C1)NC(=S)NC(=O)C2=CC=C(C=C2)F)S(=O)(=O)NC3=CC(=CC=C3)Cl

Phosphatidylcholine transfer protein inhibitor-1（Cat No.:I041075）is a small molecule designed to inhibit the activity of phosphatidylcholine transfer protein (PC-TP), a protein involved in the transfer of phosphatidylcholine between cellular membranes. By blocking PC-TP, this inhibitor can alter lipid metabolism, which plays a critical role in regulating cellular membrane composition, signaling, and energy homeostasis. Research suggests that inhibition of PC-TP could have therapeutic potential in metabolic diseases, such as obesity, diabetes, and cardiovascular diseases, by modulating lipid distribution and improving cellular function. It also holds promise in cancer therapy, where lipid signaling is dysregulated.